Antimicrobial lasso peptides
US-2026092086-A1 · Apr 2, 2026 · US
US9290768B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9290768-B2 |
| Application number | US-201313935325-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 3, 2013 |
| Priority date | Jul 3, 2012 |
| Publication date | Mar 22, 2016 |
| Grant date | Mar 22, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides for a method of genetically modifying microorganisms to enhance resistance to ionic liquids, host cells genetically modified in accordance with the methods, and methods of using the host cells in a reaction comprising biomass that has been pretreated with ionic liquids.
Opening claim text (preview).
What is claimed is: 1. A method of increasing the yield from a reaction in which soluble sugars are a source of carbon, the method comprising incubating a microorganism with biomass pretreated with an ionic liquid, wherein the biomass pretreated with an ionic liquid provides a source of soluble sugars as a carbon source, wherein the microorganism comprises a heterologous gene encoding a Major Facilitator Superfamily 1 (MFS 1) polypeptide operably linked to a promoter, wherein said MFS 1 polypeptide has an amino acid sequence with at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NO:2, and wherein said MFS 1 polypeptide facilitates resistance of the microorganism to said ionic liquid as compared to a microorganism without said heterologous gene. 2. The method of claim 1 , wherein said biomass is incubated with said microorganism in a fermentation reaction that produces an alcohol. 3. The method of claim 1 , wherein said MFS 1 polypeptide comprises the amino acid sequence of SEQ ID NO:2. 4. The method of claim 1 , wherein said heterologous gene is operably linked to a tet repressor sequence. 5. The method of claim 4 , wherein said microorganism is genetically modified to express a tet repressor protein that binds to the tet repressor sequence. 6. The method of claim 1 , wherein said microorganism is a bacteria. 7. The method of claim 6 , wherein said bacteria is Escherichia coli. 8. The method of claim 1 , wherein said microorganism is a yeast or a filamentous fungi. 9. The method of claim 1 , wherein said ionic liquid comprises an anion, wherein said anion is Cl— or acetate. 10. The method of claim 1 , wherein said heterologous gene encoding said MFS 1 polypeptide is integrated into the genome of said microorganism. 11. The method of claim 1 , wherein said microorganism is generated by transforming said microorganism with an expression cassette, wherein the said expression cassette comprises said heterologous gene encoding said MFS 1 polypeptide.
Enterobacter (G) · CPC title
Processes using, or culture media containing, cellulose or hydrolysates thereof · CPC title
Vectors or expression systems specially adapted for E. coli · CPC title
substrate containing cellulosic material · CPC title
Cross-Sectional Technologies · mapped topic
Related publications grouped by family.
Answers are generated from the same data shown on this page.